- Home
- TARA vs TONX Comparison
TARA vs TONX Comparison
Compare TARA & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | TONX |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.5M | 136.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TARA | TONX |
|---|---|---|
| Price | $5.12 | $2.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $20.40 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 573.5K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 7.29 |
| Revenue | N/A | ★ $7,760,000.00 |
| Revenue This Year | N/A | $526.82 |
| Revenue Next Year | N/A | $45.45 |
| P/E Ratio | ★ N/A | $0.35 |
| Revenue Growth | N/A | ★ 3760.70 |
| 52 Week Low | $2.77 | $1.88 |
| 52 Week High | $7.82 | $29.77 |
Technical Indicators
Market Signals| Indicator | TARA | TONX |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | N/A |
| Support Level | $5.18 | N/A |
| Resistance Level | $5.80 | N/A |
| Average True Range (ATR) | 0.27 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 3.90 | 0.00 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.